Gilead Sciences Inc (GILD)
Debt-to-equity ratio
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 19,330,000 | 18,474,000 | 18,281,000 | 17,539,000 | 22,749,000 | 22,242,000 | 21,094,000 | 20,939,000 | 21,209,000 | 21,057,000 | 20,236,000 | 19,915,000 | 21,064,000 | 21,471,000 | 19,710,000 | 18,964,000 | 18,221,000 | 17,471,000 | 18,142,000 | 22,179,000 |
| Debt-to-equity ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Debt-to-equity ratio = Long-term debt ÷ Total stockholders’ equity
= $—K ÷ $19,330,000K
= 0.00
Gilead Sciences Inc has consistently maintained a debt-to-equity ratio of 0.00 over the period from March 31, 2020, to December 31, 2024, based on the provided data. A debt-to-equity ratio of 0.00 signifies that the company has no debt or a negligible amount of debt in relation to its equity. This indicates that the company primarily relies on its equity financing to support its operations and growth, rather than taking on significant debt.
Having a low or zero debt-to-equity ratio can be viewed positively by investors and creditors as it suggests lower financial risk and a stronger financial position. It implies that the company is not heavily leveraged and has a lower probability of facing financial distress due to high debt obligations.
However, it is essential to consider that a very low debt-to-equity ratio may also indicate a conservative financial strategy where the company may be missing opportunities to leverage debt for potential growth or expansion. Overall, a debt-to-equity ratio of 0.00 for Gilead Sciences Inc reflects a conservative capital structure and potentially a strong financial standing.
Peer comparison
Dec 31, 2024